Table 2.
The association between CDAI and hyperlipidemia.
| Character | Model 1 | Model 2 | Model 3 | |||
|---|---|---|---|---|---|---|
| 95%CI | p | 95%CI | p | 95%CI | p | |
| CDAI | 0.97 (0.97, 0.98) | <0.0001 | 0.97 (0.97, 0.98) | <0.0001 | 0.98 (0.96, 0.99) | 0.01 |
| CDAIQ | ||||||
| Q1 | 1 (ref) | 1 (ref) | 1 (ref) | |||
| Q2 | 0.96 (0.84, 1.09) | 0.50 | 0.93 (0.81, 1.06) | 0.28 | 0.91 (0.78, 1.06) | 0.21 |
| Q3 | 0.86 (0.76, 0.97) | 0.01 | 0.84 (0.74, 0.95) | 0.01 | 0.85 (0.73, 1.00) | 0.05 |
| Q4 | 0.76 (0.67, 0.86) | <0.0001 | 0.75 (0.66, 0.85) | <0.0001 | 0.77 (0.64, 0.94) | 0.01 |
| p for trend | <0.0001 | <0.0001 | 0.01 | |||
Model 1: non-adjusted.
Model 2: adjusted age, gender, race.
Model 3: adjusted age, gender, race, education, marital, PIR, smoke, alcohol, eGFR, BMI, energy, carbohydrate, total, cholesterol, DM, hypertension, CHD, antiHyperlipidemic.